Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial.

Autor: Perumal Kannabiran B; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Palaniappan NA; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Manoharan T; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Paramasivam PK; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Saini JK; Department of Pulmonary Oncology, National Institute for Tuberculosis and Respiratory Diseases, New Delhi, India., Ansari MS; Department of Respiratory Medicine, Bhagwan Mahavir Medical Hospital and Research Centre, Hyderabad, India., Jayabal L; District TB office, Greater Chennai Corporation, Chennai, India., Aggarwal AN; Department of Respiratory Medicine, Post Graduate Institute of Medical Research, Chandigarh, India., Garg R; Department of Respiratory Medicine, King George's Medical University, Lucknow, India., Subramanyam B; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Thakur D; Department of Respiratory Medicine, Post Graduate Institute of Medical Research, Chandigarh, India., Pantula S; Department of Respiratory Medicine, Bhagwan Mahavir Medical Hospital and Research Centre, Hyderabad, India., P M R; Department of Respiratory Medicine, Government Thiruvotteeswarar Hospital of Thoracic Medicine, Chennai, India., Gs V; Department of Respiratory Medicine, Institute of Thoracic Medicine, Chennai, India., Natarajan S; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Ammayappan RK; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Manpreet B; Department of Pulmonary Oncology, National Institute for Tuberculosis and Respiratory Diseases, New Delhi, India., Ganesan M; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Angamuthu D; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Chinnaiyan P; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Singh M; Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India., Chandrasekaran P; Department of Clinical Resarch, ICMR - National Institute for Research in Tuberculosis, Chennai, India., Swaminathan S; Former Chief Scientist, World Health Organisation, Geneva, Switzerland.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Feb 02; Vol. 11 (3), pp. ofae034. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).

Outpatient Clinical Markers for Laryngopharyngeal Reflux Disease: A Correlational Study.

Autor: Paramasivam PK; Department of ENT, Command Hospital Airforce Bangalore, Cambridge Layout, AGARAM Post, Bangalore, Karnataka 560007 India., Sahu PK; Department of ENT, Command Hospital Airforce Bangalore, Cambridge Layout, AGARAM Post, Bangalore, Karnataka 560007 India., Bishnoi T; Department of ENT, Command Hospital Airforce Bangalore, Cambridge Layout, AGARAM Post, Bangalore, Karnataka 560007 India., Dutta A; Department of ENT, Command Hospital Airforce Bangalore, Cambridge Layout, AGARAM Post, Bangalore, Karnataka 560007 India., Yadav MK; Department of ENT, Command Hospital Airforce Bangalore, Cambridge Layout, AGARAM Post, Bangalore, Karnataka 560007 India., Marlapudi SK; Department of ENT, Command Hospital Airforce Bangalore, Cambridge Layout, AGARAM Post, Bangalore, Karnataka 560007 India.

Publikováno v: Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India [Indian J Otolaryngol Head Neck Surg] 2023 Sep; Vol. 75 (3), pp. 2042-2048. Date of Electronic Publication: 2023 Apr 25.

Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.

Autor: Velayutham BV; Department of Clinical Research., Allaudeen IS; Department of Clinical Research., Sivaramakrishnan GN; Department of Bacteriology., Perumal V; Department of Statistics, National Institute for Research in Tuberculosis (Indian Council of Medical Research)., Nair D; Department of Clinical Research., Chinnaiyan P; Department of Statistics, National Institute for Research in Tuberculosis (Indian Council of Medical Research)., Paramasivam PK; Department of Clinical Research., Dhanaraj B; Department of Clinical Research., Santhanakrishnan RK; Department of Clinical Research., Navaneethapandian GP; Department of Clinical Research., Marimuthu MK; Department of Clinical Research., Kumar V; Department of Bacteriology., Kandasamy C; Department of Statistics, National Institute for Research in Tuberculosis (Indian Council of Medical Research)., Dharuman K; Department of Clinical Research., Elangovan T; Department of Clinical Research., Narasimhan M; Department of Institute of Thoracic Medicine., Rathinam S; Department of Tuberculosis and Chest Diseases, Government Stanley Medical College Hospital., Vadivelu G; Government Thiruvateeswarar Hospital, Chennai., Rathinam P; Department of Thoracic Medicine, Government Rajaji Hospital, Madurai., Chockalingam C; Government Hospital for Thoracic Medicine, Tambaram., Jayabal L; Chennai Corporation, India., Swaminathan S; Department of Clinical Research., Shaheed JM; Department of Clinical Research.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2014 Nov 15; Vol. 59 (10), pp. e142-9. Date of Electronic Publication: 2014 Jul 14.